Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 401

1.
3.

Antiarrhythmic and cardiohemodynamic effects of a novel Ca(2+) channel blocker, AH-1058, assessed in canine arrhythmia models.

Takahara A, Sugiyama A, Dohmoto H, Yoshimoto R, Hashimoto K.

Eur J Pharmacol. 2000 Jun 9;398(1):107-12.

PMID:
10856454
4.

In vivo antiarrhythmic profile of AP-792 assessed in different canine arrhythmia models.

Takahara A, Hirasawa A, Dohmoto H, Shoji M, Yoshimoto R, Sugiyama A, Hashimoto K.

Jpn J Pharmacol. 2001 Sep;87(1):21-6.

5.

Effects of AH-1058, a new antiarrhythmic drug, on experimental arrhythmias and cardiac membrane currents.

Takahara A, Uneyama H, Sasaki N, Ueda H, Dohmoto H, Shoji M, Hara Y, Nakaya H, Yoshimoto R.

J Cardiovasc Pharmacol. 1999 Apr;33(4):625-32.

PMID:
10218734
6.
7.

Calcium antagonistic and antiarrhythmic actions of CPU-23, a substituted tetrahydroisoquinoline.

Dong H, Sheng JZ, Lee CM, Wong TM.

Br J Pharmacol. 1993 May;109(1):113-9.

8.

Effects of dantrolene sodium in rodent models of cardiac arrhythmia.

Brooks RR, Carpenter JF, Jones SM, Gregory CM.

Eur J Pharmacol. 1989 May 30;164(3):521-30.

PMID:
2767123
9.

Efficacy of the class III antiarrhythmic agent azimilide in rodent models of ventricular arrhythmia.

Brooks RR, Carpenter JF, Miller KE, Maynard AE.

Proc Soc Exp Biol Med. 1996 May;212(1):84-93.

PMID:
8618956
10.

Actions of a newly synthesized compound (711389-S) on various types of experimentally induced arrhythmias in mammalian species in situ.

Kadowaki Y, Ohta T, Hotokebuchi N, Kimoto S, Haruna M, Nakao T, Ueda M, Nishi K.

Jpn J Pharmacol. 1988 Apr;46(4):359-72.

11.

Antiarrhythmic effects of LR-A/113 a new calcium antagonistic drug.

Stella L, de Novellis V, Vacca C, Guarino A, Cantoni V, Fici F, Rossi F.

Res Commun Mol Pathol Pharmacol. 1996 Aug;93(2):235-48.

PMID:
8884994
12.

Antiarrhythmic effect of KB-944, a new calcium antagonist. A comparison with verapamil and diltiazem.

Yoshidomi M, Sukamoto T, Morita T, Ito K, Nose T.

Arzneimittelforschung. 1982;32(9):1056-9.

PMID:
6890826
13.

Antiarrhythmic plasma concentrations of NIK-244 on canine ventricular arrhythmias.

Hashimoto K, Matsuzaki T, Haruno A.

J Cardiovasc Pharmacol. 1989 Dec;14(6):892-8.

PMID:
2481779
14.

The antiarrhythmic and cardiovascular properties of 1-dimethyl isopropylamino-3-(2-phenylphenoxy)-propan-2-ol chloride, UM-424.

Kniffen FJ, Winokur S, Counsell RE, Lucchesi BR.

J Pharmacol Exp Ther. 1976 Feb;196(2):420-32.

PMID:
3643
15.

Effects of dofetilide, a class III antiarrhythmic drug, on various ventricular arrhythmias in dogs.

Chen J, Xue Y, Eto K, Ni C, Hashimoto K.

J Cardiovasc Pharmacol. 1996 Oct;28(4):576-84.

PMID:
8891885
16.

The protective effects of CP-060S on ischaemia- and reperfusion- induced arrhythmias in anaesthetized rats.

Koga T, Fukazawa M, Suzuki Y, Akima M, Adachi Y, Tamura K, Kato T, Kuromaru O.

Br J Pharmacol. 1998 Apr;123(7):1409-17.

17.

Antiarrhythmic effects of a new drug, E-0747, on canine ventricular arrhythmia models.

Mitsuhashi H, Akiyama K, Hashimoto K, Sawa Y, Hatori Y.

Jpn J Pharmacol. 1987 Jun;44(2):155-62.

18.
19.

[Effects of lorcainide, a new antiarrhythmic agent, on experimental cardiac arrhythmias].

Fukuda H, Goto M, Kondo M, Uchigasaki T, Sekino Y.

Nihon Yakurigaku Zasshi. 1983 Feb;81(2):115-26. Japanese.

PMID:
6852683
20.

The antiarrhythmic effect and possible ionic mechanisms of pilocarpine on animal models.

Zhao WM, Qi HP, Liu Y, Chen W, Xie J, Pan ZY, Han HM, Chen LP, Li DL, Wang LY, Sun HL, Liu Y.

J Cardiovasc Pharmacol Ther. 2009 Sep;14(3):242-7. doi: 10.1177/1074248409339308.

PMID:
19721134
Items per page

Supplemental Content

Write to the Help Desk